Management of Trauma-Induced Coagulopathy with Thrombelastography

Critical Care Clinics

Volumn 33, Issue 1, 2017, Pages 119-134

  Gonzalez, Eduardo ^a   Moore, Ernest E ^a,b,c   Moore, Hunter B ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c Journal of Trauma and Acute Care Surgery   (United States)

Author keywords

Coagulopathy; Fibrinolysis; Resuscitation; TEG; Thrombelastography; Transfusion

Indexed keywords

ACTIVATED CLOTTING TIME; BLOOD CLOT LYSIS; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CLOT FORMATION ANGLE; CONTROLLED CLINICAL TRIAL (TOPIC); EMERGENCY HEALTH SERVICE; EQUIPMENT DESIGN; EUROPE; FIBRIN FORMATION; FIBRINOLYSIS; HEMATOLOGICAL PARAMETERS; HUMAN; MAXIMUM AMPLITUDE; NORTH AMERICA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REACTION TIME; RESUSCITATION; REVIEW; ROTATIONAL THROMBELASTOMETRY; SHEAR ELASTIC MODULUS STRENGTH; SOFTWARE; THROMBOELASTOGRAPH; THROMBOELASTOGRAPHY; TRAUMA INDUCED COAGULOPATHY; VISCOELASTICITY; BLOOD COAGULATION DISORDERS; COMPLICATION; PRACTICE GUIDELINE; STANDARDS; WOUNDS AND INJURIES;

BLOOD COAGULATION DISORDERS; EUROPE; HUMANS; NORTH AMERICA; PRACTICE GUIDELINES AS TOPIC; THROMBELASTOGRAPHY; WOUNDS AND INJURIES;

EID: 84997719754     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2016.09.002     Document Type: Review

References (57)

1. 1 Norton, R., Kobusingye, O., Injuries. N Engl J Med 368:18 (2013), 1723–1730.
2. 2 MacKenzie, E.J., Rivara, F.P., Jurkovich, G.J., et al. A national evaluation of the effect of trauma-center care on mortality. N Engl J Med 354:4 (2006), 366–378.
3. 3 Rhee, P., Joseph, B., Pandit, V., et al. Increasing trauma deaths in the United States. Ann Surg 260:1 (2014), 13–21.
4. 4 Sauaia, A., Gonzalez, E., Moore, H.B., et al. Fatality and severity of firearm injuries in a Denver Trauma Center, 2000-2013. JAMA 315:22 (2016), 2465–2467.
5. 5 Trunkey, D.D., Trauma. Accidental and intentional injuries account for more years of life lost in the U.S. than cancer and heart disease. Among the prescribed remedies are improved preventive efforts, speedier surgery and further research. Sci Am 249:2 (1983), 28–35.
6. 6 Zambon, M., Vincent, J.L., Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 133:5 (2008), 1120–1127.
7. 7 Ciesla, D.J., Moore, E.E., Johnson, J.L., et al. Decreased progression of postinjury lung dysfunction to the acute respiratory distress syndrome and multiple organ failure. Surgery 140:4 (2006), 640–647 [discussion: 647–8].
8. 8 Tisherman, S.A., Schmicker, R.H., Brasel, K.J., et al. Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the resuscitation outcomes consortium. Ann Surg 261:3 (2015), 586–590.
9. 9 Brohi, K., Singh, J., Heron, M., et al. Acute traumatic coagulopathy. J Trauma 54:6 (2003), 1127–1130.
10. 10 MacLeod, J.B., Lynn, M., McKenney, M.G., et al. Early coagulopathy predicts mortality in trauma. J Trauma 55:1 (2003), 39–44.
11. 11 Torres, L.N., Sondeen, J.L., Ji, L., et al. Evaluation of resuscitation fluids on endothelial glycocalyx, venular blood flow, and coagulation function after hemorrhagic shock in rats. J Trauma Acute Care Surg 75:5 (2013), 759–766.
12. 12 Cotton, B.A., Harvin, J.A., Kostousouv, V., et al. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg 73:2 (2012), 365–370 [discussion: 370].
13. 13 Nielsen, V.G., Hemodilution with lactated Ringer's solution causes hypocoagulability in rabbits. Blood Coagul Fibrinolysis 15:1 (2004), 55–59.
14. 14 Nielsen, V.G., Lyerly, R.T. 3rd, Gurley, W.Q., The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation. Anesth Analg 99:6 (2004), 1587–1592.
15. 15 Moore, H.B., Moore, E.E., Gonzalez, E., et al. Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage. J Am Coll Surg 220:5 (2015), 872–879.
16. 16 Gonzalez, E., Moore, H., Moore, E.E., Trauma Induced Coagulopathy. 2016, Springer International Publishing AG, Switzerland.
17. 17 Gonzalez, E., Moore, E.E., Moore, H.B., et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg 263:6 (2016), 1051–1059.
18. 18 Hartert, H., Blutgerinnungsstudien mit der Thrombelastographie; einem neuen Untersuchungs verfahren. Klin Wochenschr 26:37–38 (1948), 577–583.
19. 19 De Nicola, P., Mazzetti, G.M., Evaluation of thrombelastography. Am J Clin Pathol 23:4 (1955), 447–452.
20. 20 Von Kaulla, K.N., Weiner, M., Studies of coagulation and fibrinolysis by new technic of continuous recording. Blood 10:4 (1955), 362–369.
21. 21 Von Kaulla, K.N., Swan, H., Clotting deviations in man during cardiac bypass: fibrinolysis and circulating anticoagulant. J Thorac Surg 36:4 (1958), 519–530.
22. 22 Kang, Y.G., Martin, D.J., Marquez, J., et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 64:9 (1985), 888–896.
23. 23 Von Kaulla, K.N., Kaye, H., von Kaulla, E., et al. Changes in blood coagulation. Arch Surg 92:1 (1966), 71–79.
24. 24 Tuman, K.J., Spiess, B.D., McCarthy, R.J., et al. Comparison of viscoelastic measures of coagulation after cardiopulmonary bypass. Anesth Analg 69:1 (1989), 69–75.
25. 25 Gibbs, N.M., Crawford, G.P., Michalopoulos, N., Thrombelastographic patterns following abdominal aortic surgery. Anaesth Intensive Care 22:5 (1994), 534–538.
26. 26 Wasowicz, M., Srinivas, C., Meineri, M., et al. Technical report: analysis of citrated blood with thromboelastography: comparison with fresh blood samples. Can J Anaesth 55:5 (2008), 284–289.
27. 27 Vig, S., Chitolie, A., Bevan, D.H., et al. Thromboelastography: a reliable test?. Blood Coagul Fibrinolysis 12:7 (2001), 555–561.
28. 28 Bowbrick, V.A., Mikhailidis, D.P., Stansby, G., The use of citrated whole blood in thromboelastography. Anesth Analg 90:5 (2000), 1086–1088.
29. 29 Zambruni, A., Thalheimer, U., Leandro, G., et al. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 15:1 (2004), 103–107.
30. 30 Johansson, P.I., Bochsen, L., Andersen, S., et al. Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography. Transfusion 48:11 (2008), 2377–2383.
31. 31 Nielsen, V.G., Cohen, B.M., Cohen, E., Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 49:2 (2005), 222–231.
32. 32 Gonzalez, E., Moore, E.E., Moore, H.B., et al. Trauma-induced coagulopathy: an institution's 35 year perspective on practice and research. Scand J Surg 103:2 (2014), 89–103.
33. 33 Moore, H.B., Moore, E.E., Chin, T.L., et al. Activated clotting time of thrombelastography (T-ACT) predicts early postinjury blood component transfusion beyond plasma. Surgery 156:3 (2014), 564–569.
34. 34 Cotton, B.A., Faz, G., Hatch, Q.M., et al. Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission. J Trauma 71:2 (2011), 407–414 [discussion: 414–7].
35. 35 Harr, J.N., Moore, E.E., Ghasabyan, A., et al. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock (Augusta, Ga) 39:1 (2013), 45–49.
36. 36 Montupil, J., Carlier, C., Van der Linden, P., Use of fibrinogen concentrate in bleeding patients. Anaesthesia 70:11 (2015), 1323–1324.
37. 37 Bowbrick, V.A., Mikhailidis, D.P., Stansby, G., Influence of platelet count and activity on thromboelastography parameters. Platelets 14:4 (2003), 219–224.
38. 38 Kornblith, L.Z., Kutcher, M.E., Redick, B.J., et al. Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis. J Trauma Acute Care Surg 76:2 (2014), 255–256 [discussion: 262–3].
39. 39 Galanakis, D.K., Neerman-Arbez, M., Brennan, S., et al. Thromboelastographic phenotypes of fibrinogen and its variants: clinical and non-clinical implications. Thromb Res 133:6 (2014), 1115–1123.
40. 40 Quinn, B., Gonzalez, E., Moore, E.E., et al. Defining the optimal thrombelastography assay to detect tissue plasminogen induced fibrinolysis. Surgery, 2016 in press.
41. 41 Moore, H.B., Moore, E.E., Gonzalez, E., et al. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg 77:6 (2014), 811–817.
42. 42 Quarterman, C., Shaw, M., Johnson, I., et al. Intra- and inter-centre standardisation of thromboelastography (TEG(R)). Anaesthesia 69:8 (2014), 883–890.
43. 43 Einersen, P.M., Moore, E.E., Chapman, M.P., et al. Rapid-thromboelastography (r-TEG) thresholds for goal-directed resuscitation of patients at risk for massive transfusion. J Trauma Acute Care Surg, 2016 [Epub ahead of print].
44. 44 Owen, C.A. Jr., Historical account of tests of hemostasis. Am J Clin Pathol 93:4 Suppl 1 (1990), S3–S8.
45. 45 Eckman, M.H., Erban, J.K., Singh, S.K., et al. Screening for the risk for bleeding or thrombosis. Ann Intern Med 138:3 (2003), W15–W24.
46. 46 Kaufmann, C.R., Dwyer, K.M., Crews, J.D., et al. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 42:4 (1997), 716–720 [discussion: 720–2].
47. 47 Kashuk, J.L., Moore, E.E., The emerging role of rapid thromboelastography in trauma care. J Trauma 67:2 (2009), 417–418.
48. 48 Kashuk, J.L., Moore, E.E., Sawyer, M., et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg 251:4 (2010), 604–614.
49. 49 Gonzalez, E., Pieracci, F.M., Moore, E.E., et al. Coagulation abnormalities in the trauma patient: the role of point-of-care thromboelastography. Semin Thromb Hemost 36:7 (2010), 723–737.
50. 50 Tapia, N.M., Chang, A., Norman, M., et al. TEG-guided resuscitation is superior to standardized MTP resuscitation in massively transfused penetrating trauma patients. J Trauma Acute Care Surg 74:2 (2013), 378–385 [discussion: 385–6].
51. 51 Chin, T.L., Moore, E.E., Moore, H.B., et al. A principal component analysis of postinjury viscoelastic assays: clotting factor depletion versus fibrinolysis. Surgery 156:3 (2014), 570–577.
52. 52 Kutcher, M.E., Ferguson, A.R., Cohen, M.J., A principal component analysis of coagulation after trauma. J Trauma Acute Care Surg 74:5 (2013), 1223–1229 [discussion: 1229–30].
53. 53 Schochl, H., Frietsch, T., Pavelka, M., et al. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 67:1 (2009), 125–131.
54. 54 Kashuk, J.L., Moore, E.E., Sawyer, M., et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 252:3 (2010), 434–442 [discussion: 443–4].
55. 55 Shakur, H., Roberts, I., Bautista, R., et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376:9734 (2010), 23–32.
56. 56 Napolitano, L.M., Cohen, M.J., Cotton, B.A., et al. Tranexamic acid in trauma: how should we use it?. J Trauma Acute Care Surg 74:6 (2013), 1575–1586.
57. 57 Chapman, M.P., Moore, E.E., Ghasabyan, A., et al. TEG fibrinolysis above 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg 75:6 (2013), 961–967.